Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

  • Antiviral Res. 2020 Jun;178:104805. doi: 10.1016/j.antiviral.2020.104805.
Mike Bray ,  Craig Rayner ,  François Noël ,  David Jans ,  Kylie Wagstaff
PMID: 32330482 DOI: 10.1016/j.antiviral.2020.104805
Products